Suppression of Murine Endotoxin Response by E5531, a Novel Synthetic Lipid A Antagonist

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1998-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.42.11.2824PMID 9797210PMCID PMC105950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs

  1995cited by this paper
• Anti-endotoxin activity of a novel synthetic lipid A analog.

  1995cited by this paper
• E5531, a pure endotoxin antagonist of high potency.

  1995cited by this paper
• Use of CD14 transfected cells to study LPS-antagonist action.

  1995cited by this paper
• Therapeutic trial of lipid X in a canine model of septic shock.

  1993cited by this paper
• Endotoxin receptors on mammalian cells.

  1993cited by this paper
• Lipopolysaccharide (LPS) binding to 73-kDa and 38-kDa surface proteins on lymphoreticular cells: preferential inhibition of LPS binding to the former by Rhodopseudomonas sphaeroides lipid A.

  1993cited by this paper
• Lipopolysaccharide antagonists.

  1992cited by this paper
• A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

  1991cited by this paper
• Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X

  1991cited by this paper
• Gram‐negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction 1

  1991cited by this paper
• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

  1991cited by this paper
• Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.

  1991influential reference
• Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice

  1991cited by this paper
• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

  1991cited by this paper
• Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice.

  1990cited by this paper
• Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice.

  1990influential reference
• Highly purified lipid X is devoid of immunostimulatory activity. Isolation and characterization of immunostimulating contaminants in a batch of synthetic lipid X.

  1990cited by this paper
• Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo

  1990cited by this paper
• Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.

  1990cited by this paper
• Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS

  1990cited by this paper
• The cardiovascular response of normal humans to the administration of endotoxin.

  1989cited by this paper
• Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide

  1989cited by this paper
• The Enzyme Linked Immunosorbent Assay (ELISA)

  1987cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor.

  1986cited by this paper
• Protection of Mice against Lethal Endotoxemia by a Lipid A Precursor

  1986cited by this paper
• Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative.

  1985cited by this paper
• Human T-cell hybridomas producing lymphokines. II. Enhancement of lymphotoxin secretion from human T-cell hybridomas by phorbol myristate acetate.

  1983cited by this paper
• TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI

  1983cited by this paper
• Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

  1982cited by this paper
• Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.

  1982cited by this paper
• BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.

  1980cited by this paper
• Galactosamine-induced sensitization to the lethal effects of endotoxin.

  1979influential reference
• Bacterial Endotoxins (Part 2 of 2)

  1975cited by this paper
• Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture.

  1975cited by this paper
• Biological activities of lipid A complexed with bovine-serum albumin.

  1972cited by this paper
• STATISTICAL METHODS

  1967cited by this paper
• [Bacterial endotoxins].

  1967cited by this paper
• Sensitivity of Mice to Endotoxin after Vaccination with BCG (Bacillus Calmette-Guérin)∗

  1958cited by this paper
• Transaminase activity in human blood.

  1955cited by this paper

• Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments

  2022cites this paper
• Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation

  2021cites this paper
• Plugging the Leak in Dengue Shock.

  2018cites this paper
• In vivo Proinflammatory Cytokine Production by CD-1 Mice in Response to Equipotential Doses of Rhodobacter capsulatus PG and Salmonella enterica Lipopolysaccharides

  2018cites this paper
• The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design.

  2016cites this paper
• Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways.

  2014cites this paper
• Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.

  2008cites this paper
• Screening of anti-endotoxin components fromRadix isatidis

  2008cites this paper
• Immunobiological activities of a new nontoxic lipopolysaccharide from Acidiphilium GS18h/ATCC55963, a soil isolate from an Indian copper mine.

  2006influential citation
• Effective dosing of lipid A analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection.

  2006influential citation
• Screening of anti-endotoxin components from Radix isatidis.

  2006cites this paper
• Development of an injectable formulation for the novel lipid A analog E5531 using a 'pH-jump method'.

  2004cites this paper
• Forward genetic dissection of afferent immunity: the role of TIR adapter proteins in innate and adaptive immune responses.

  2004cites this paper
• Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex.

  2003cites this paper
• Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist

  2003influential citation
• Stimulation of Toll-Like Receptor 4 by Lipopolysaccharide During Cellular Invasion by Live Salmonella typhimurium Is a Critical But Not Exclusive Event Leading to Macrophage Responses1

  2003cites this paper
• Salmonella enterica Serovar Typhimurium Expressing Mutant Lipid A with Decreased Endotoxicity Causes Maturation of Murine Dendritic Cells

  2003cites this paper
• Safety, Pharmacokinetics, and Pharmacodynamics of E5564, a Lipid A Antagonist, during an Ascending Single‐Dose Clinical Study

  2003cites this paper
• Palytoxin: an inexhaustible source of inspiration—personal perspective

  2002cites this paper
• Endotoxin antagonism: conceptual basis and therapeutic potential

  2002cites this paper
• Inhibition of Endotoxin Response by E 5564 , a Novel TLR 4-Directed Endotoxin Antagonist

  2002cites this paper
• Invited review: Bacterial lipopolysaccharides and innate immunity

  2001cites this paper
• Bacterial lipopolysaccharides and innate immunity.

  2001cites this paper
• Induction of TNF-alpha and MnSOD by endotoxin: effect of E5531, a synthetic non-toxic lipid A analog.

  2000cites this paper
• Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E5564 and E5531

  2000cites this paper
• The Effect of Lipid A Analog E5531 on Membrane Properties of Dipalmitoylphosphatidylcholine

  2000cites this paper
• Induction of TNF-α and MnSOD by endotoxin: effect of E5531, a synthetic non-toxic lipid A analog

  2000cites this paper
• Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E5564 and E5531.

  2000cites this paper
• Comparison of the Effect of Lipid A Analog E5531 and the Lipid A from Escherichia coli on Phospholipid Membrane Properties

  2000cites this paper
• E5531, a synthetic non‐toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide

  1999cites this paper